Search

everythinglearnresearchcommunity

for

Search:↓

Glucocorticoid and mineralocorticoid therapy effectively manage Congenital Adrenal Hyperplasia symptoms but have limitations.

Abnormal adrenal function is not the cause of alopecia in Pomeranians; it may be due to breed-specific hormones.

Combining modern and Unani treatments may offer better care for hirsutism in PCOS.

Genetic variants in CYP genes may worsen PCOS symptoms.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Sebaceous glands in our skin, developing during pregnancy and active in puberty, produce sebum for skin lubrication, temperature control, and fighting germs, also help in hormone regulation, and their dysfunction can cause conditions like acne and hair loss.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Skin health and diseases are closely linked to metabolic processes.

Topical spironolactone cream doesn't cause hormone-related side effects in the body.

Obese women with PCOS have lower vitamin D levels.

Finger length ratio may indicate male hair loss.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Women with PCOS often have sexual problems, and treating these issues early can improve satisfaction and reduce healthcare costs.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

The Cyp11a1 gene variation has a weak link to PCOS, but higher di-hydro-testosterone levels are found in PCOS patients.

Insulin resistance is strongly linked to higher androgen levels in women with PCOS.

A rare case of Cushing syndrome was successfully treated with one-sided adrenal gland removal, suggesting personalized treatment is important.

Certain hormone levels can help diagnose P450 oxidoreductase deficiency.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

Obesity worsens PCOS symptoms, and PCOS may lead to more weight gain; managing both requires a holistic approach that includes mental health.